DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,002,507 | +1.7% | 12,102 | -1.5% | 0.61% | +8.1% |
| Q2 2023 | $2,952,239 | -6.4% | 12,288 | -1.7% | 0.57% | -10.8% |
| Q1 2023 | $3,154,181 | -5.4% | 12,502 | -0.3% | 0.64% | -6.2% |
| Q4 2022 | $3,332,675 | -0.6% | 12,545 | -3.3% | 0.68% | +1.8% |
| Q3 2022 | $3,353,000 | +1.4% | 12,969 | -0.4% | 0.67% | +3.9% |
| Q2 2022 | $3,306,000 | -13.5% | 13,027 | +0.0% | 0.64% | +0.2% |
| Q1 2022 | $3,820,000 | -14.4% | 13,024 | -3.9% | 0.64% | -19.6% |
| Q4 2021 | $4,461,000 | +6.6% | 13,559 | -1.3% | 0.80% | -1.6% |
| Q3 2021 | $4,183,000 | +6.0% | 13,739 | -6.6% | 0.81% | +10.8% |
| Q2 2021 | $3,948,000 | +11.0% | 14,711 | -6.9% | 0.73% | +2.8% |
| Q1 2021 | $3,557,000 | -0.2% | 15,805 | -1.5% | 0.71% | -9.5% |
| Q4 2020 | $3,563,000 | -8.4% | 16,041 | -11.2% | 0.79% | -17.7% |
| Q3 2020 | $3,890,000 | +15.9% | 18,065 | -4.8% | 0.96% | +8.2% |
| Q2 2020 | $3,357,000 | +27.3% | 18,984 | -0.4% | 0.88% | +10.2% |
| Q1 2020 | $2,638,000 | +1.3% | 19,062 | +12.3% | 0.80% | +25.2% |
| Q4 2019 | $2,604,000 | +5.0% | 16,968 | -1.1% | 0.64% | -5.3% |
| Q3 2019 | $2,479,000 | -0.0% | 17,163 | -1.1% | 0.68% | -1.9% |
| Q2 2019 | $2,480,000 | +5.4% | 17,353 | -2.6% | 0.69% | +3.6% |
| Q1 2019 | $2,352,000 | +22.8% | 17,816 | -4.1% | 0.66% | +7.3% |
| Q4 2018 | $1,915,000 | -4.6% | 18,575 | +0.6% | 0.62% | -1.1% |
| Q3 2018 | $2,007,000 | +9.6% | 18,469 | -0.5% | 0.63% | +2.8% |
| Q2 2018 | $1,832,000 | +2.1% | 18,569 | +1.4% | 0.61% | -1.3% |
| Q1 2018 | $1,794,000 | +50.1% | 18,319 | +42.3% | 0.62% | +41.1% |
| Q4 2017 | $1,195,000 | +101.2% | 12,874 | +85.8% | 0.44% | +69.8% |
| Q3 2017 | $594,000 | +1.5% | 6,930 | 0.0% | 0.26% | -0.4% |
| Q2 2017 | $585,000 | -1.3% | 6,930 | 0.0% | 0.26% | -2.6% |
| Q1 2017 | $593,000 | +10.0% | 6,930 | 0.0% | 0.27% | +0.8% |
| Q4 2016 | $539,000 | -3.4% | 6,930 | -2.7% | 0.26% | -6.0% |
| Q3 2016 | $558,000 | -22.9% | 7,120 | -0.7% | 0.28% | -25.7% |
| Q2 2016 | $724,000 | +4.9% | 7,170 | -1.4% | 0.38% | -2.3% |
| Q1 2016 | $690,000 | -0.6% | 7,270 | -2.7% | 0.39% | -5.4% |
| Q4 2015 | $694,000 | +8.9% | 7,470 | 0.0% | 0.41% | +7.1% |
| Q3 2015 | $637,000 | -2.3% | 7,470 | -1.9% | 0.38% | -1.5% |
| Q2 2015 | $652,000 | -2.7% | 7,615 | -3.5% | 0.39% | -2.0% |
| Q1 2015 | $670,000 | -19.1% | 7,888 | -18.4% | 0.40% | -26.3% |
| Q4 2014 | $828,000 | +11.3% | 9,663 | -1.3% | 0.54% | -16.0% |
| Q3 2014 | $744,000 | -9.8% | 9,788 | -6.5% | 0.64% | -10.5% |
| Q2 2014 | $825,000 | -30.5% | 10,473 | -33.8% | 0.71% | -43.5% |
| Q1 2014 | $1,187,000 | -6.0% | 15,828 | -3.2% | 1.26% | -28.0% |
| Q4 2013 | $1,263,000 | – | 16,354 | – | 1.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |